本页面由Tiger Trade Technology Pte. Ltd.提供服务

神经分泌生物科学

135.13
-6.2400-4.41%
盘后:134.21-0.9152-0.68%19:13 EDT
成交量:156.83万
成交额:2.13亿
市值:137.83亿
市盈率:19.81
高:139.93
开:139.60
低:134.89
收:141.37
52周最高:186.12
52周最低:122.14
股本:1.02亿
流通股本:9,999.56万
量比:1.32
换手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
净资产收益率:22.09%
总资产收益率:11.70%
市净率:3.73
市盈率(LYR):28.94

数据加载中...

2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

重要事件披露

Current report, items 2.02, 5.02, 5.03, and 9.01
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/11

超过5%披露

General statement of acquisition of beneficial ownership
2019/12/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/05

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/05

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/05

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/10/16

持股变动声明

Statement of changes in beneficial ownership of securities